Medical applications of membranes: Drug delivery, artificial organs and tissue engineering

Journal of Membrane Science

Volumn 308, Issue 1-2, 2008, Pages 1-34

  Stamatialis, Dimitrios F ^a   Papenburg, Bernke J ^a   Gironés, Miriam ^a   Saiful, Saiful ^a   Bettahalli, Srivatsa N M ^a   Schmitmeier, Stephanie ^b   Wessling, Matthias ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Artificial organs; Drug delivery; Medical applications; Membranes; Tissue engineering

Indexed keywords

DRUG DELIVERY SYSTEMS; TRANSDERMAL DELIVERY SYSTEMS;

ARTIFICIAL ORGANS; DRUG DELIVERY; MEDICAL APPLICATIONS; OXYGENATION;

TISSUE ENGINEERING;

CLONIDINE; ESTRADIOL; FENTANYL; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NICOTINE; SCAFFOLD PROTEIN; TRANSDERM; UNCLASSIFIED DRUG;

ARTIFICIAL ORGANS; DRUG DELIVERY; MEDICAL APPLICATIONS; OXYGENATION; TISSUE ENGINEERING;

ARTIFICIAL KIDNEY; ARTIFICIAL LIVER; ARTIFICIAL MEMBRANE; ARTIFICIAL ORGAN; ARTIFICIAL PANCREAS; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOREACTOR; BLOOD OXYGENATION; CELL CULTURE; CELL FRACTIONATION; CELL SEPARATION; DIALYSIS; DIFFUSION; DRUG DELIVERY SYSTEM; EMULSION; FOAMING; HUMAN; IMPLANT; IONTOPHORESIS; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; OSMOSIS; PILL; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TRANSDERMAL DRUG ADMINISTRATION;

EID: 37349078343     PISSN: 03767388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.memsci.2007.09.059     Document Type: Review

References (332)

1. Baker R.W. Membrane Technology and Applications (2004), Wiley & Sons Ltd., Chichester, England
2. Mulder M. Basic Principles of Membrane Technology (1996), Kluwer Academic, Dordrecht
3. Peppas N.A., and Langer R. New challenges in biomaterials. Science 263 (1994) 1715-1720
4. Williams D.F. In: Williams D.F. (Ed). Definitions in Biomaterials: Proceedings of a Consensus Conference of the European Society for Biomaterials (1987), Elsevier, Chester, England
5. Black J. Biological Performance of Materials: Fundamentals of Biocompatibility (2006), Taylor & Francis, Boca Raton
6. Yoshida M., Langer R., Lendlein A., and Lahann J. From advanced biomedical coatings to multi-functionalized biomaterials. Polym. Rev. 46 4 (2006) 347-375
7. Reis R.L., and San Roman J. Biodegradable Systems in Tissue Engineering and Regenerative Medicine (2005), CRC Press, Boca Raton
8. Strathmann H., and Gohl H. In: Klinkmann H., and Smeby L. (Eds). Membranes for Blood Purification: State of the Art and New Developments. Terminal Renal Failure: Therapeutic Problems, Possibilities and Potentials vol. 78 (1990), Kanger, S., Basel 119-141
9. Sun S., Yue Y., Huang X., and Meng D. Protein adsorption on blood-contact membranes. J. Membr. Sci. 222 (2003) 3-18
10. Diamantoglou M., Lemke H.D., and Vienken J. Cellulose-ester as membrane materials for hemodialysis. Int. J. Artif. Organs 17 7 (1994) 385-391
11. Diamantoglou M., Platz J., and Vienken J. Cellulose carbamates and derivatives as hemocompatible membrane materials for hemodialysis. Artif. Organs 23 1 (1999) 15-22
12. Vienken J., Diamantoglou M., Hahn C., Kamusewitz H., and Paul D. Considerations on developmental aspects of biocompatible dialysis membranes. Artif. Organs 19 5 (1995) 398-406
13. Deppisch R., Storr M., Buck R., and Gohl H. Blood material interactions at the surfaces of membranes in medical applications. Sep. Purif. Technol. 14 (1998) 241-254
14. Groth T., Seifert B., Albrecht W., Malsch G., Gross U., Fey-Lamprecht F., Michanetzis G., Missirlis Y., and Engbers G. Development of polymer membranes with improved haemocompatibility for biohybrid organ technology. Clin. Hemorheol. Microcirc. 32 2 (2005) 129
15. Seifert B., Mihanetzis G., Groth T., Albrecht W., Richau K., Missirlis Y., Paul D., and Von Sengbusch G. Polyetherimide: a new membrane-forming polymer for biomedical applications. Artif. Organs 26 2 (2002) 189
16. Lutzow K., Weigel T., and Lendlein A. Poly(ether imide) scaffolds as multifunctional materials for potential applications in regenerative medicine. Artif. Organs 30 10 (2006) 764
17. Altankov G., Albrecht W., Richau K., Groth T., and Lendlein A. On the tissue compatibility of poly(ether imide) membranes: an in vitro study on their interaction with human dermal fibroblasts and keratinocytes, Journal of Biomaterials Science. Polym. Ed. 16 1 (2005) 23
18. Albrecht W., Seifert B., Weigel T., Schossig M., Hollander A., Groth T., and Hilke R. Amination of poly(ether imide) membranes using di- and multivalent amines. Macromol. Chem. Phys. 204 3 (2003) 510
19. Santoso F., Albrecht W., Schroeter M., Weigel T., Paul D., and Schomacker R. A novel technique for preparation of aminated polyimide membranes with microfiltration characteristics. J. Membr. Sci. 223 1-2 (2003) 171
20. Hench L.L., and Jones J.R. Biomaterials Artificial Organs and Tissue Engineering (2005), CRC Press, Boca Raton
21. Simo C., Cifuentes A., and Gallardo A. Drug delivery systems: polymers and drugs monitored by capillary electromigration methods. J. Chromatogr. B 797 (2003) 37-49
22. Baker R.W. Controlled Release of Biologically Active Agents (1987), New York
23. Kuethe D.D., Augestein D.C., Cresser J.D., and Wise D.L. Design of capsules that burst at predetermined times by dialysis. J. Controll. Release 18 (1992) 159
24. Thombre A.G., Cardinal J.R., DeNoto A.R., and Gibbes D.C. Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance. J. Controll. Release 57 1 (1999) 65
25. Michaels A.S., Wong P.S.L., Prather R., and Gale R.M. A thermodynamic method of predicting the transport of steroids in polymer matrices. AIChE J. 21 6 (1975) 1073-1080
26. Chien Y.W. Polymer Controlled Drug Delivery Systems (1985), Plenum Press, New York and London
27. Ito T., Hioki T., Yamaguchi T., Shinbo T., Nakao S.I., and Kimura S. Development of a molecular recognition ion gating membrane and estimation of its pore size control. J. Am. Chem. Soc. 124 26 (2002) 7840
28. Chu L.Y., Park S.H., Yamaguchi T., and Nakao S. Preparation of thermo-responsive core-shell microcapsules with a porous membrane and poly(N-isopropylacrylamide) gates. J. Membr. Sci. 192 1-2 (2001) 27
29. Chu L.Y., Niitsuma T., Yamaguchi T., and Nakao S.i. Thermoresponsive transport through porous membranes with grafted PNIPAM gates. AIChE J. 49 4 (2003) 896
30. Okano T., Bae Y.H., Jacobs H., and Kim S.W. Thermally on-off switching polymers for drug permeation and release. J. Controll. Release 11 1-3 (1990) 255
31. Ichikawa H., and Fukumori Y. Negatively thermosensitive release of drug from microcapsules with hydroxypropyl cellulose membranes prepared by the Wurster process. Chem. Pharm. Bull. 47 8 (1999) 1102
32. Choi Y.J., Yamaguchi T., and Nakao S.I. A novel separation system using porous thermosensitive membranes. Ind. Eng. Chem. Res. 39 7 (2000) 2491
33. Peng T., and Cheng Y.L. Temperature-responsive permeability of porous PNIPAAm-g-PE membranes. J. Appl. Polym. Sci. 70 11 (1998) 2133
34. Obaidat A.A., and Park K. Characterization of protein release through glucose-sensitive hydrogel membranes. Biomaterials 18 11 (1997) 801
35. Chu L.-Y., Liang Y.-J., Chen W.-M., Ju X.-J., and Wang H.-D. Preparation of glucose-sensitive microcapsules with a porous membrane and functional gates. Colloids Surf. B Biointerfaces 37 1-2 (2004) 9
36. Discher D.E., and Ahmed F. Polymersomes. Ann. Rev. Biomed. Eng. 8 (2006) 323
37. Meng F., Hiemstra C., Engbers G.H.M., and Feijen J. Biodegradable polymersomes. Macromolecules 36 9 (2003) 3004
38. Meng F., Engbers G.H.M., and Feijen J. Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting. J. Controll. Release 101 1-3 Spec. Iss. (2005) 187
39. Arifin D.R., and Palmer A.F. Polymersome encapsulated hemoglobin: a novel type of oxygen carrier. Biomacromolecules 6 4 (2005) 2172
40. Ahmed F., Pakunlu R.I., Brannan A., Bates F., Minko T., and Discher D.E. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J. Controll. Release 116 2 Spec. Iss. (2006) 150
41. Barry B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14 2 (2001) 101
42. Banga A.K. Electrically Assisted Transdermal and Topical Drug Delivery (1998), Taylor & Francis Ltd., London
43. Sugibayashi K., and Morimoto Y. Polymers for transdermal drug delivery systems. J. Controll. Release 29 1-2 (1994) 177
44. Stamatialis D.F., Rolevink H.H.M., and Koops G.H. Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions. J. Controll. Release 81 3 (2002) 335
45. Kalia Y.N., Naik A., Garrison J., and Guy R.H. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 56 5 (2004) 619
46. Rein H. Experimental studies on electroosmosis in surviving human skin. Z. Biol. 81 (1924) 125-140
47. Pikal M.J., and Shah S. Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin. Pharm. Res. 7 3 (1990) 213
48. Denet A.R., Ucakar B., and Preat V. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach. Pharm. Res. 20 12 (2003) 1946
49. Schuetz Y.B., Naik A., Guy R.H., Vuaridel E., and Kalia Y.N. Transdermal iontophoretic delivery of triptorelin in vitro. J. Pharm. Sci. 94 10 (2005) 2175
50. Tokumoto S., Mori K., Higo N., and Sugibayashi K. Effect of electroporation on the electroosmosis across hairless mouse skin in vitro. J. Controll. Release 105 3 (2005) 296
51. Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 46 1-3 (2000) 281
52. Van der Geest R., Danhof M., and Bodde H.E. Validation and testing of a new iontophoretic continuous flow through transport cell. J. Controll. Release 51 1 (1998) 85
53. Jadoul A., Bouwstra J., and Preat V. Effects of iontophoresis and electroporation on the stratum corneum: review of the biophysical studies. Adv. Drug Deliv. Rev. 35 1 (1999) 89
54. Stamatialis D.F., Rolevink H.H.M., and Koops G.H. Delivery of timolol through artificial membranes and pig stratum corneum. J. Pharm. Sci. 92 5 (2003) 1037
55. Stamatialis D.F., Rolevink H.H., Balster J., and Koops G.H. Controlled drug delivery through tailor-made blend polymeric membranes. J. Controll. Release 101 1-3 (2005) 302
56. Stamatialis D.F., Rolevink H.H., Girones M., Nymeijer D.C., and Koops G.H. In vitro evaluation of a hydroxypropyl cellulose gel system for transdermal delivery of timolol. Curr. Drug Deliv. 1 4 (2004) 313
57. Stamatialis D.F., Rolevink H.H., and Koops G.H. Passive and iontophoretic controlled delivery of salmon calcitonin through artificial membranes. Curr. Drug Deliv. 1 2 (2004) 137
58. Vasil'ev A.E., Krasnyuk I.I., Ravikumar S., and Tokhmakhchi V.N. Drug synthesis methods and manufacturing technology, transdermal therapeutic systems for controlled drug release (a review). Pharm. Chem. J. 35 11 (2001) 613-626
59. Uhlenbusch-Korwer I., Bonnie-Schorn E., Grassmann A., and Vienken J. Understanding Membranes and Dialysers (2004), Pabst Science Publishers, Lengerich, Germany
60. Abel J.J., Rowntree L.G., and Turner B.B. On the removal of diffusible substances from the circulating blood by means of dialysis. Trans. Assoc. Am. Phys. 28 (1913) 50-54
61. Haas G. Versuche der blutauswachung am lebenden mit hilfe de dialyse. Klin. Wochenschr. 4 (1925) 13-14
62. Kolff W.J., and Berk H.T.J. De kunstmatige nier: een dialysator met en groot oppenflak. Ned. Tijdschr. Geneeskd. 87 (1943) 1684
63. Kolff W.J., Berk H.T.J., ter Welle M., Ley A.J.W., van Dijk E.C., and van Noordwijk J. The artificial kidney: a dialyser with a great area. Acta Med. Scand. 117 (1944) 121-134
64. Bowry S.K. Dialysis membranes today. Int. J. Artif. Organs 25 5 (2002) 447-460
65. Craddock P.R., Fehr J., and Dalmasso A.P. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J. Clin. Invest. 59 5 (1977) 879-888
66. Craddock P.R., Fehr J., and Brigham K.L. Complement and leukocyte mediated pulmonary dysfunction in hemodialysis. N. Engl. J. Med. 296 14 (1977) 769-774
67. Falkenhagen D., Bosch T., Brown G.S., Schmidt B., Holtz M., Baurmeister U., Gurland H., and Klinkmann H. A clinical study on different cellulosic dialysis membranes. Nephrol. Dial. Transplant. 2 6 (1987) 537-545
68. Von Sengbusch G., Bowry S., and Vienken J. Focusing on membranes. Artif. Organs 17 4 (1993) 244-253
69. Hoenich N.A., Woffindin C., Mathews J.N.S., and Vienken J. Biocompatibility of membranes used in the treatment of renal failure. Biomaterials 16 8 (1995) 587
70. Hoenich N.A., Woffindin C., Cox P.J., Goldfinch M., and Roberts S.J. Clinical characterization of Dicea a new cellulose membrane for haemodialysis. Clin. Nephrol. 48 4 (1997) 253-259
71. Hoenich N.A., Woffindin C., Stamp S., Roberts S.J., and Turnbull J. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?. Biomaterials 18 19 (1997) 1299-1303
72. Lucchi L., Bonucchi D., Acerbi M.A., Cappelli G., Spattini A., Innocenti M., Castellani A., and Lusvarghi E. Improved biocompatibility by modified cellulosic membranes: the case of hemophan. Artif. Organs 13 5 (1989) 417-421
73. Hoenich N., and Ronco C. In: Winchester J., Koch K., Jacobs C., and Kjiellestrand C. (Eds). Replacement of Renal Function by Dialysis (1996), Kluwer Academic, Dordrecht 256-270
74. Krause B., Storr M., Ertl T., Buck R., Hildwein H., Deppisch R., and Gohl H. Polymeric membranes for medical applications. Chem. Ingenieur Tech. 75 11 (2003) 1725
75. Barzin J., Feng C., Khulbe K.C., Matsuura T., Madaeni S.S., and Mirzadeh H. Characterization of polyethersulfone hemodialysis membrane by ultrafiltration and atomic force microscopy. J. Membr. Sci. 237 1-2 (2004) 77
76. Ronco C., Crepaldi C., Brendolan A., Bragantini L., d'Intini V., Inguaggiato P., Bonello M., Krause B., Deppisch R., Goehl H., and Scabardi A. Evolution of synthetic membranes for blood purification: the case of the Polyflux family. Nephrol. Dial. Transplant. 18 Suppl. 7 (2003)
77. Vienken J. Polymers in nephrology: characteristics and needs. Int. J. Artif. Organs 25 5 (2002) 470
78. Klinkmann H., Baurmeister U., and Davison A.M. The consensus conference on biocompatibility: a contribution to the solution of the biocompatibility puzzle. Nephrol. Dial. Transplant. 9 Suppl. 2 (1994) 1-2
79. Broek A.P., Teunis H.A., Bargeman D., Sprengers E.D., and Smolders C.A. Characterization of hollow fiber hemodialysis membranes: pore size distribution and performance. J. Membr. Sci. 73 2-3 (1992) 143
80. Bender H., Pflanzel A., Saunders N., Czermak P., Catapano G., and Vienken J. Membranes for endotoxin removal from dialysate: considerations on feasibility of commercial ceramic membranes. Artif. Organs 24 10 (2000) 826
81. Czermak P., Ebrahimi M., and Catapano G. New generation ceramic membranes have the potential of removing endotoxins from dialysis water and dialysate. Int. J. Artif. Organs 28 7 (2005) 694
82. Langsdorf L.J., and Zydney A.L. Diffusive and convective solute transport through hemodialysis membranes: a hydrodynamic analysis. J. Biomed. Mater. Res. 28 5 (1994) 573
83. Vanholder R., De Smet R., and Lameire N. Protein-bound uremic solutes: the forgotten toxins. Kidney Int. Suppl. 59 78 (2001) S266-S270
84. Hayama M., Miyasaka T., Mochizuki S., Asahara H., Yamamoto K.-i., Kohori F., Tsujioka K., and Sakai K. Optimum dialysis membrane for endotoxin blocking. J. Membr. Sci. 219 1-2 (2003) 15
85. Moachon N., Boullanger C., Fraud S., Vial E., Thomas M., and Quash G. Influence of the charge of low molecular weight proteins on their efficacy of filtration and/or adsorption on dialysis membranes with different intrinsic properties. Biomaterials 23 3 (2002) 651
86. Gao D., and Clark W.R. In: Bhattacharyya D., and Butterfield D.A. (Eds). New Insights into Membrane Science and Technology: Polymeric and Biofunctional Membranes (2003), Elsevier B.V., Amsterdam 219-232
87. Ronco C., Scabardi M., Goldoni M., Brendolan A., Crepaldi C., and La Greca G. Impact of spacing filaments external to hollow fibers on dialysate flow distribution and dialyzer performance. Int. J. Artif. Organs 20 5 (1997) 261
88. Gohl H., Raff M., Harttig H., and Deppisch R. PC-PE hollow-fiber membrane. Structure, performance characteristics and manufacturing. Blood Purif. 4 1-3 (1986) 23
89. B. Krause, M. Hornung, T. Ertl, M. Storr, WO2006106133, Filtration membrane, 2006.
90. F. Wechs, EP1718399, Integral membrane, method and producing said membrane and use thereof, 2006.
91. R. Buck, H. Goehl, WO2004056460, Permselective aymmetric hollow fiber membrane for the separation of toxic mediators from blood, 2004.
92. H. Gohl, R. Buck, KR20050083852, Permselective membrane and process for manufacturing thereof, 2005.
93. B. Krause, M. Wessling, H. Gohl, M. Storr, KR20050090373, Membrane and use thereof, 2005.
94. U. Baurmeister, US6918886, Membrane module for the hemodiafiltration with integrated pre- or postdilution of the blood, 2005.
95. M. Pirner, H. Goehl, J. Dannenmeier, KR20040089559, Filter device having at least two filtration compartments filtering more than one fluid, 2004.
96. N. Moachon, M. Thomas, US2005045554, Membrane unit element, semipermeable membrane, filtration device, and process for manufacturing the same, 2005.
97. Opatrny Jr. K., Krouzecky A., Polanska K., Mares J., Tomsu M., Bowry S.K., and Vienken J. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?. Hemodial. Int. 10 2 (2006) 201-208
98. Raff M., Welsch M., Gohl H., Hildwein H., Storr M., and Wittner B. Advanced modeling of high flux hemodialysis. J. Membr. Sci. 216 1-2 (2003) 1
99. Humes H.D., Fissell W.H., and Tiranathanagul K. The future of hemodialysis membranes. Kidney Int. 69 7 (2006) 1115
100. Yatzidis H. A convenient haemoperfusion micro-apparatus for treatment of endegeneous and exogenous intoxicatons; its use as an effective artificial kidney. Proc. Eur. Dial. Transplant. Assoc. 1 (1964) 83-87
101. Davankov V., Pavlova L., Tsyurupa M., Brady J., Balsamo M., and Yousha E. Polymeric adsorbent for removing toxic proteins from blood of patients with kidney failure. J. Chromatogr. B Biomed. Sci. Appl. 739 1 (2000) 73-80
102. Ronco C., Brendolan A., Dan M., Piccinni P., Bellomo R., De Nitti C., Inguaggiato P., and Tetta C. Use of sorbent in acute renal failure and sepsis. Contribut. Nephrol. 133 (2001) 180-193
103. Wang Y.J., Wang Z.W., Luo B.W., Liu H.L., and Wen H.W. Assessment of resin perfusion in hepatic failure in vitro and in vivo. World J. Gastroenterol. 10 6 (2004) 837
104. Winchester J.F., Ronco C., Brady J.A., Cowgill L.D., Salsberg J., Yousha E., Choquette M., Albright R., Clemmer J., Davankov V., Tsyurupa M., Pavlova L., Pavlov M., Cohen G., Ho?rl W., Gotch F., and Levin N.W. The next step from high-flux dialysis: application of sorbent technology. Blood Purif. 20 1 (2002) 81-88
105. Mikhalovsky S.V. Emerging technologies in extracorporeal treatment: focus on adsorption. Perfusion 18 Suppl. 1 (2003) 47-54
106. Tefferi A., Kumar S., Wolf R.C., Lacy M.Q., Gloor D.J.I.J.M., Albright R.C., Kamath P.S., and Litzow M.R. Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Bone Marrow Transplant. 28 (2001) 997-999
107. Winchester F.J., Ronco C., Salsberg J., Yousha E., Brady J.A., Cowgill L.D., Choquette M., Albright R., Clemmer J., Davankov V., Tsyurupa M., Pavlova L., Pavlov M., Cohen G., Ho?rl W., Gotch F., and Levin N.W. Sorbent augmented dialysis systems. Contribut. Nephrol. 137 (2002) 170-180
108. Rahman M.H., Haqqie S.S., and McGoldrick M.D. Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion. Hemodial. Int. 10 3 (2006) 256-259
109. Ash S.R., Knab W.R., Steczko J., Carr D.J., and Blake D.E. Hepatic treatment by powered sorbent pheresis-the Biologic-DTPF system. Am. Soc. Artif. Intern. Organs J. 44 (1998) 92A
110. Winchester J.F., Kellum J.A., Ronco C., Brady J.A., Quartararo P.J., Salsberg J.A., and Levin N.W. Sorbents in acute renal failure and the systemic inflammatory response syndrome. Blood Purif. 21 1 (2003) 79
111. Julius U., Metzler W., Pietzsch J., Faßbender T., and Klingel R. Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP. Int. J. Artif. Organs 25 12 (2002) 1180-1188
112. Abe T., Shono M., Kodama T., Kita Y., Fukagawa M., and Akizawa T. Extracorporeal albumin dialysis. Ther. Apheresis Dial. 8 3 (2004) 217-222
113. Jaeger B.R. The HELP system for the treatment of atherothrombotic disorders: a review. Ther. Apheresis 7 4 (2003) 391-396
114. van Dijk B., Vonk C.R., and Dijkhuis I.C. Detoxification of toxic agents from the blood. Clinical results with a new hemoperfusion system. de Hemopur 260 32(16) (1979) 728-736
115. Staudt A., Staudt Y., Hummel A., Empen K., Dörr M., Trimpert C., Birkenmeier K., Kühl U., Noutsias M., Russ D., and Felix S.B. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther. Apheresis Dial. 10 1 (2006) 42-48
116. Nakamura T., Matsuda T., Suzuki Y., Ueda Y., and Koide H. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans. ASAIO J. 49 4 (2003) 430-434
117. Suzuki K., Shimazaki M., and Kutsuki H. Beta-2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis. Ther. Apheresis 7 (2003) 104-107
118. Mitzner S.R., Stange J., Klammt S., Peszynski P., and Schmidt R. Albumin dialysis using the molecular adsorbent recirculating system. Curr. Opin. Nephrol. Hypertens. 10 6 (2001) 777-783
119. ® adsorber. Transfus. Apheresis Sci. 29 1 (2003) 93-98
120. Nakaji S., and Hayashi N. Adsorption column for myasthenia gravis treatment: Medisorba MG-50. Ther. Apheresis 7 1 (2003) 78-84
121. Nakaji S., and Hayashi N. Bilirubin adsorption column Medisorba BL-300. Ther. Apheresis Dial. 7 1 (2003) 98-103
122. Pineda A.A. Selective therapeutic extraction of plasma constituents, revisited. Transfusion 39 7 (1999) 671-673
123. Sugimoto K., Yamaji K., Yang K.-S., Kanai Y., Tsuda H., and Hashimoto H. Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis. Ther. Apheresis Dial. 10 2 (2006) 187-192
124. Ryan C.J., Anilkumar T., Ben-Hamida A.J.A., Khorsandi S.E., Aslam M., Pusey C.D., Gaylor J.D.S., and Courtney J.M. Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma. Artif. Organs 25 2 (2001) 109-118
125. Nakamura T., Matsuda T., Suzuki Y., Shoji H., and Koide H. Polymyxin B-immobilized fiber hemoperfusion in patients with sepsis. Dial. Transplant. 32 10 (2003) 602-609
126. Eventov V.L., Andrianova Y.M., and Kukaeva E.A. Regeneration hemodialysis systems. Biomed. Eng. 35 2 (2001) 103-109
127. Koll R.A., Klinkmann J., Richter W.O., and RheoSorb:. A specific adsorber for fibrinogen elimination in clinical situations with impaired rheology. Artif. Organs 26 2 (2002) 145-151
128. Suzuki K. The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus. Ther. Apheresis 4 3 (2000) 239-243
129. Freedman J., Rand M.L., Russell O., Davis C., Cheatley P.L., Blanchette V., and Garvey M.B. Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII. Transfusion 43 11 (2003) 1508-1513
130. Taniguchi T., Hirai F., Takemoto Y., Tsuda K., Yamamoto K., Inaba H., Sakurai H., Furuyoshi S., and Tani N. A novel adsorbent of circulating bacterial toxins and cytokines: the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia. Crit. Care Med. 34 3 (2006) 800-806
131. Cole L., Bellomo R., Davenport P., Tipping P., Uchino S., Tetta C., and Ronco C. The effect of coupled haemofiltration and adsorption on inflammatory cytokines in an ex vivo model. Nephrol. Dial. Transplant. 17 11 (2002) 1950-1956
132. Falkenhagen D., Strobl W., Hartmann J., Schrefl A., Linsberger I., Kellner K.-H., Aussenegg F., and Leitner A. Patient safety technology for microadsorbent systems in extracorporeal blood purification. Artif. Organs 26 2 (2002) 84-90
133. Erturk E., Haberal M., and Piskin E. Towards the commercialization of a hemoperfusion column. Part I. Selection of activated carbon. Clin. Mater. 2 1 (1987) 55-65
134. Winchester F.J. Dialysis and hemoperfusion in poisoning. Adv. Ren. Replace. Ther. 9 1 (2002) 26-30
135. Chang T.M.S. Performance Characteristics of The Microcapsule Artificial Kidney (1974), Sector Publisher, London
136. Wilson I.D. Encyclopedia of Separation Science (2000), Academic press, San Diego
137. Castilho L.R., Anspach F.B., and Deckwer W.-D. Comparison of affinity membranes for the purification of immunoglobulins. J. Membr. Sci. 207 2 (2002) 253
138. Ghosh R. Protein separation using membrane chromatography: opportunities and challenges. J. Chromatogr. A 952 1-2 (2002) 13
139. Avramescu M.E., Borneman Z., and Wessling M. Dynamic behavior of adsorber membranes for protein recovery. Biotechnol. Bioeng. 84 5 (2003) 564
140. Avramescu M.E., Borneman Z., and Wessling M. Mixed-matrix membrane adsorbers for protein separation. J. Chromatogr. A 1006 1-2 (2003) 171
141. Avramescu M.E., Girones M., Borneman Z., and Wessling M. Preparation of mixed matrix adsorber membranes for protein recovery. J. Membr. Sci. 218 1-2 (2003) 219
142. Avramescu M.E., Sager W.F.C., Mulder M.H.V., and Wessling M. Preparation of ethylene vinylalcohol copolymer membranes suitable for ligand coupling in affinity separation. J. Membr. Sci. 210 1 (2002) 155
143. Saiful Z., Borneman M., and Wessling. Enzyme capturing and concentration with mixed matrix membrane adsorbers. J. Membr. Sci. 280 1-2 (2006) 406
144. Avramescu M.E., Sager W.F.C., and Wessling M. Functionalised ethylene vinyl alcohol copolymer (EVAL) membranes for affinity protein separation. J. Membr. Sci. 216 1-2 (2003) 177
145. Avramescu M.E., Sager W.F.C., Borneman Z., and Wessling M. Adsorptive membranes for bilirubin removal. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 803 2 (2004) 215
146. Klein E. In: Crespo J.G., and Boddeker K.W. (Eds). Membrane Processes in Separation and Purification (1994), Kluwer Academic, Amsterdam 85-107
147. Cattoli F., and Sarti G.C. In: Bhattacharyya D., and Butterfield D.A. (Eds). New Insights into the Membrane Science and Technology: Polymeric and Biofunctional Membranes vol. 8 (2003), Elsevier, Amsterdam 263-281
148. Demmer W., Fischer-Fruhholz S., Nubbaumer D., and Melzner D. In: Bhattacharyya D., and Butterfield D.A. (Eds). New Insights into the Membrane Science and Technology: Polymeric and Biofunctional Membranes vol. 8 (2003), Elsevier, Amsterdam 283-295
149. Urmenyi A.M., Philipse A.P., Lammertink R.G.H., and Wessling M. Polymer-in-a-silica-crust membranes: macroporous materials with tunable surface functionality. Langmuir 22 12 (2006) 5459-5468
150. Urmenyi A.M., Poot A.A., Wessling M., and Mulder M.H.V. Affinity membranes for hormone removal from aqueous solutions. J. Membr. Sci. 259 1-2 (2005) 91-102
151. S. Karoor, L. Henderson, J. Molina, WO0041718, Method and apparatus for selectively removing xenoreactive antibodies from blood, serum or plasma, 2000.
152. N. Ofsthun, P.J. Soltys, G.A. Kunas, US5871649, Affinity membrane system and method of using same, 1999.
153. M. Mueller, C. Oehr, H. Malthaner, H. Goehl, R. Deppisch, M. Storr, WO03090910, A process for production of a regioselective membrane, 2003.
154. Kellum J.A., and Venkataraman R. Application of blood purification to non-renal organ failure. Int. J. Artif. Organs 28 5 (2005) 445
155. Stromberg R.R., Friedman L.I., Boggs D.R., and Lysaght M.J. Membrane technology applied to donor plasmapheresis. J. Membr. Sci. 44 1 (1989) 131
156. Zydney A.L., and Colton C.K. Continuous flow membrane plasmapheresis: theoretical models for flux and hemolysis prediction. Trans. Am. Soc. Artif. Intern. Organs 28 (1982) 408
157. Solomon B.A., Castino F., and Lysaght M.J. Continuous flow membrane filtration of plasma from whole blood. Trans. Am. Soc. Artif. Organs 24 (1978) 21
158. Jaffrin M.Y. Innovative processes for membrane plasma separation. J. Membr. Sci. 44 1 (1989) 115
159. Burnouf T., Radosevich M., El-Ekiaby M., Satoh S., Sato T., Amin S.N., Savidge G.F., and Goubran H.A. Nanofiltration of single plasma donations: feasibility study. Vox Sang. 84 2 (2003) 111
160. Bellomo R., Tetta C., and Ronco C. Coupled plasma filtration adsorption. Intensive Care Med. 29 8 (2003) 1222
161. Atkinson S. Blood filtration and treatment. Membr. Technol. 2004 1 (2004) 8
162. Gura V., Beizai M., Ezon C., and Rambod E. Continuous renal replacement therapy for congestive heart failure: the wearable continuous ultrafiltration system. ASAIO J. 52 1 (2006) 59
163. Castino F., and Wickramasinghe S.R. Washing frozen red blood cell concentrates using hollow fibres. J. Membr. Sci. 110 2 (1996) 169
164. Aoki M., Yasutake M., and Murohara T. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 22 6 (2004) 994
165. Higuchi A., Shindo Y., Gomei Y., Mori T., Uyama T., and Umezawa A. Cell separation between mesenchymal progenitor cells through porous polymeric membranes. J. Biomed. Mater. Res. Part B Appl. Biomater. 74 1 (2005) 511
166. Higuchi A., Yamamiya S.I., Yoon B.O., Sakurai M., and Hara M. Peripheral blood cell separation through surface-modified polyurethane membranes. J. Biomed. Mater. Res. Part A 68 1 (2004) 34
167. Noda M., Matsuoka Y., Hayashi S., and Higuchi A. Separation of vascular endothelial cells from peripheral blood through porous polymeric membranes. Polym. Preprints Jpn. 55 (2006) 1920
168. Feruglio C., Savignano C., Silvestri F., Rinaldi C., Lavaroni S., Venturelli F., Degrassi A., Fanin R., Sala P.G., Biffoni F., and Baccarani M. Effect of marrow processing on hematopoietic cell recovery in bone marrow harvests: focus on filtration. Bone Marrow Transplant. 16 6 (1995) 835
169. Iwahashi H., Yuri K., and Nose Y. Development of the oxygenator: past, present, and future. J. Artif. Organs 7 3 (2004) 111
170. Clowes Jr. G.H., Hopkins A.L., and Nevillen I. An artificial lung dependent upon diffusion of oxygen and carbon dioxide through plastic membrane. J. Thorac. Surg. 32 (1956) 630-637
171. Kolff W.J., Watschinger B., and Vertes V. Results in patients treated with the coil kidney (disposable dialyzing unit). J. Am. Med. Assoc. 11 16 (1956) 1433-1437
172. Effler D.B., Groves L.K., Kolff W.J., and Sone Jr. M. Disposable membrane oxygenator (heart-lung machine) and its use in experimental surgery. J. Thorac. Surg. 32 (1956) 620-629
173. Kolobow T., and Bowman R.L. Construction and evaluation of alveolar membrane artificial heart-lung. Trans. Am. Soc. Artif. Intern. Organs 9 (1963) 238-243
174. Kolobow T., Spragg R.G., Pierce J.E., and Zapol W.M. Extended term (to 16 days) partial extracorporeal blood gas exchange with the spiral membrane lung in unanesthetized lambs. Trans. Am. Soc. Artif. Intern. Organs 17 (1971) 350
175. Nosé Y., and Malchesky P.S. In: Oda T. (Ed). Therapeutic Plasmapheresis (1981), F.K. Schattauer, Stuttgart 3-14
176. Suma K., Tsuji T., and Takeuchi Y. Clinical performance of microporous polypropylene hollow-fiber oxygenator. Ann. Thorac. Surg. 32 6 (1981) 558
177. Niimi Y., Ueyama K., Yamaji K., Yamane S., Tayama E., Sueoka A., Kuwana K., Tahara K., and Nose Y. Effects of ultrathin silicone coating of porous membrane on gas transfer and hemolytic performance. Artif. Organs 21 10 (1997) 1082
178. Motomura T., Maeda T., Kawahito S., Matsui T., Ichikawa S., Ishitoya H., Kawamura M., Nishimura I., Shinohara T., Oestmann D., Glueck J., Kawaguchi Y., Sato K., and Nose Y. Extracorporeal membrane oxygenator compatible with centrifugal blood pumps. Artif. Organs 26 11 (2002) 952
179. Lai J.Y., Hsu F.C., and Hung B.N. Composites for artificial lung membranes by plasma deposition. IEEE/Engineering in Medicine and Biology Society Annual Conference (1986) 1632
180. Shih C.Y., Lee K.-R., and Lai J.Y. 60Co [gamma]-ray irradiation modified poly(4-methyli-pentene) membrane for oxygenator. Eur. Polym. J. 30 5 (1994) 629
181. Lin F.-C., Wang D.-M., and Lai J.-Y. Asymmetric TPX membranes with high gas flux. J. Membr. Sci. 110 1 (1996) 25
182. M.O. Mueller, E. Kessler, R.R. Hornscheitdt, F. Wiese, A.J. Lang, US6409921, Integrally asymmetrical polyolefin membrane for gas exchange, 2002.
183. E. Kessler, T. Batzilla, F. Wechs, F. Wiese, US6375876, Method for producing an integrally asymmetrical polyolefin membrane, 2002.
184. E. Kessler, T. Batzilla, F. Wechs, F. Wiese, US6497752, Integrally asymmetrical polyolefin membrane, 2002.
185. Mielck F., and Quintel M. Extracorporeal membrane oxygenation. Curr. Opin. Crit. Care 11 1 (2005) 87
186. Nogawa A. The future of artificial lungs: an industry perspective. J. Artif. Organs 5 4 (2002) 211
187. E. Kessler, T. Batzilla, F. Wechs, F. Wiese, WO03061812, Polyolefin membrane with an integrally asymmetric structure and method for the production thereof, 2003.
188. Iwasaki Y., Uchiyama S., Kurita K., Morimoto N., and Nakabayashi N. A nonthrombogenic gas-permeable membrane composed of a phospholipid polymer skin film adhered to a polyethylene porous membrane. Biomaterials 23 16 (2002) 3421
189. Queiroz D.P., and Norberta de Pinho M. Structural characteristics and gas permeation properties of polydimethylsiloxane/poly(propylene oxide) urethane/urea bi-soft segment membranes. Polymer 46 7 (2005) 2346
190. Kawakami H., Kanamori T., and Kubota S. Development of a fluorinated polyimide hollow fiber for medical devices. J. Artif. Organs 6 2 (2003) 124
191. T. Keller, K. Heilmann, S. Fritzsche, I. Raiko, R. Sander, DE10034098, Production of microporous polysulfone hollow-fiber membrane, useful for membrane oxygenation of blood, involves coating gas side of membrane with hydrophobic material, 2002.
192. Z. Wu, J.F. Antaki, B.P. Griffith, WO2006031858, Blood pump-oxygenator system, 2006.
193. D. Raible, WO9716213, Extracorporeal blood oxygenation system having integrated blood pump, heat exchanger and membrane oxygenator, 1997.
194. Mazaheri A.R., and Ahmadi G. Uniformity of the fluid flow velocities within hollow fiber membranes of blood oxygenation devices. Artif. Organs 30 1 (2006) 10
195. Wickramasinghe S.R., and Han B. Designing microporous hollow fibre blood oxygenators. Chem. Eng. Res. Des. 83 3A (2005) 256
196. Nagase K., Kohori F., and Sakai K. Oxygen transfer performance of a membrane oxygenator composed of crossed and parallel hollow fibers. Biochem. Eng. J. 24 2 (2005) 105
197. Catapano G., Papenfuss H.D., Wodetzki A., and Baurmeister U. Mass and momentum transport in extra-luminal flow (ELF) membrane devices for blood oxygenation. J. Membr. Sci. 184 1 (2001) 123
198. Catapano G., Hornscheidt R., Wodetzki A., and Baurmeister U. Turbulent flow technique for the estimation of oxygen diffusive permeability of membranes for the oxygenation of blood and other cell suspensions. J. Membr. Sci. 230 1-2 (2004) 131
199. 2 removal with hydrophilic membranes from slowly flowing blood. J. Membr. Sci. 273 1-2 (2006) 89
200. M. Gartner, US2005042131, Blood oxygenator with spacers, 2005.
201. J.D. Filho, J.F. Bischegli, WO9958171, Low prime membrane oxygenator with integrated heat exchanger/reservoir, 1999.
202. Reng M., Philipp A., Kaiser M., Pfeifer M., Gruene S., and Schoelmerich J. Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet 356 (2000) 219-220
203. Kmiec Z. In: Beck F., Christ B., Kriz W., Kummer W., Marani E., Putz R., Sano Y., Schiebler T.H., Schoenwolf G.C., and Zilles K. (Eds). Advances in Anatomy Embryology and Cell Biology vol. 161 (2001), Springer-Verlag, Berlin Heidelberg New York 1-149
204. Gimson A.E. Fulminant and late onset hepatic failure. Br. J. Anaesth. 77 1 (1996) 90-98
205. Sen S., Williams R., and Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver 22 Suppl. 2 (2002) 5-13
206. Rifai K., Bahr M., Schneider A., Ott M., and Mann M. Neue Verfahren in der Leberersatztherapie. Med. Klin. 98 (2003) 750-753
207. Rahman T.M., and Hodgson H.J. Review article: liver support systems in acute hepatic failure. Aliment. Pharmacol. Ther. 13 10 (1999) 1255-1272
208. Stockmann H.B., Hiemstra C.A., Marquet R.L., and Ijzermans J.N. Extracorporeal perfusion for the treatment of acute liver failure. Ann. Surg. 231 4 (2000) 460-470
209. Kjaergard L.L., Liu J., Als-Nielsen B., and Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. Jama 289 2 (2003) 217-222
210. Hui T., Rozga J., and Demetriou A.A. Bioartificial liver support. J. Hepatobiliary Pancreat. Surg. 8 1 (2001) 1-15
211. Van De Kerkhove M.-P., Di Florio E., Scuderi V., Mancini A., Belli A., Bracco A., Dauri M., Tisone G., Di Nicuolo G., Amoroso P., Spadari A., Lombardi G., Hoekstra R., Calise F., and Chamuleau R.A.F.M. Phase I clinical trial with the AMC-bioartificial liver. Int. J. Artif. Organs 25 10 (2002) 950-959
212. Rifai K., Ernst T., Kretschmer U., Bahr M.J., Schneider A., Hafer C., Haller H., Manns M.P., and Fliser D. Prometheus-a new extracorporeal system for the treatment of liver failure. J. Hepatol. 39 6 (2003) 984-990
213. Diekmann S., Bader A., and Schmitmeier S. Present and future developments in hepatic tissue engineering for liver support systems: state of the art and future developments of hepatic cell culture techniques for the use in liver support systems. Cytotechnology 50 (2006) 163-179
214. Nyberg S.L., Shatford R.A., Hu W.S., Payne W.D., and Cerra F.B. Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support). Crit. Care Med. 20 8 (1992) 1157-1168
215. De Bartolo L., and Bader A. Review of a flat membrane bioreactor as a bioartificial liver. Ann. Transplant. 6 3 (2001) 40-46
216. Bader A., Fruhauf N., Tiedge M., Drinkgern M., De Bartolo L., Borlak J.T., Steinhoff G., and Haverich A. Enhanced oxygen delivery reverses anaerobic metabolic states in prolonged sandwich rat hepatocyte culture. Exp. Cell Res. 246 1 (1999) 221-232
217. De Bartolo L., Morelli S., Lopez L.C., Giorno L., Campana C., Salerno S., Rende M., Favia P., Detomaso L., Gristina R., d'Agostino R., and Drioli E. Biotransformation and liver-specific functions of human hepatocytes in culture on RGD-immobilized plasma-processed membranes. Biomaterials 26 21 (2005) 4432-4441
218. De Bartolo L., Morelli S., Rende M., Gordano A., and Drioli E. New modified polyetheretherketone membrane for liver cell culture in biohybrid systems: adhesion and specific functions of isolated hepatocytes. Biomaterials 25 17 (2004) 3621-3629
219. De Bartolo L., Morelli S., Gallo M.C., Campana C., Statti G., Rende M., Salerno S., and Drioli E. Effect of isoliquiritigenin on viability and differentiated functions of human hepatocytes maintained on PEEK-WC-polyurethane membranes. Biomaterials 26 33 (2005) 6625-6634
220. Sussman N.L., Chong M.G., Koussayer T., He D.E., Shang T.A., Whisennand H.H., and Kelly J.H. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 16 1 (1992) 60-65
221. Rozga J., Holzman M.D., Ro M.S., Griffin D.W., Neuzil D.F., Giorgio T., Moscioni A.D., and Demetriou A.A. Development of a hybrid bioartificial liver. Ann. Surg. 217 5 (1993) 502-509 (discussion 509-511)
222. Mazariegos G.V., Patzer J.F., Lopez R.C., Giraldo M., Devera M.E., Grogan T.A., Zhu Y., Fulmer M.L., Amiot B.P., and Kramer D.J. First clinical use of a novel bioartificial liver support system (BLSS). Am. J. Transplant. 2 3 (2002) 260-266
223. Sauer I.M., Neuhaus P., and Gerlach J.C. Concept for modular extracorporeal liver support for the treatment of acute hepatic failure. Metab. Brain Dis. 17 4 (2002) 477-484
224. Flendrig L.M., La Soe J.W., Jorning G.G.A., Steenbeek A., Karlsen O.T., Bovee W.M.M.J., Ladiges N.C.J.J., Te Velde A.A., and Chamuleau R.A.F.M. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J. Hepatol. 26 6 (1997) 1379
225. Nyberg S.L., Shatford R.A., Payne W.D., Hu W.S., and Cerra F.B. Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: an in vitro system with application to the bioartificial liver. Rat hepatocytes cultured in cylindrical collagen gels. Cytotechnology 10 3 (1992) 205-215
226. Nyberg S.L., Hibbs J.R., Hardin J.A., Germer J.J., and Persing D.H. Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. Transplantation 67 9 (1999) 1251-1255
227. van de Kerkhove M.P., Germans M.R., Deurholt T., Hoekstra R., Joziasse D.H., van Wijk A.C., van Gulik T.M., Chamuleau R.A., and Roos A. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems. J. Hepatol. 42 4 (2005) 541-547
228. Saltzman W.M. Tissue Engineering: Principles for the Design of Replacement Organs and Tissues (2004), Oxford, New York
229. Morsiani E., Brogli M., Galavotti D., Bellini T., Ricci D., Pazzi P., and Puviani A.C. Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor. Artif. Organs 25 9 (2001) 740-748
230. Dixit V., and Gitnick G. The bioartificial liver: state-of-the-art. Eur. J. Surg. Suppl. 582 (1998) 71-76
231. Giorno L., De Bartolo L., and Drioli E. In: Bhattacharyya D., and Butterfield D.A. (Eds). New Insights into the Membrane Science and Technology: Polymeric and Biofunctional Membranes vol. 8 (2003), Elsevier, Amsterdam 187-217
232. Beck J., Angus R., Madsen B., Britt D., Vernon B., and Nguyen K.T. Islet encapsulation: strategies to enhance islet cell functions. Tissue Eng. 13 3 (2007) 589-599
233. Chick W.L., Like A.A., and Lauris V. Beta cell culture on synthetic capillaries: an artificial endocrine pancreas. Science 187 4179 (1975) 847
234. Sullivan S.J., Maki T., Borland K.M., Mahoney M.D., Solomon B.A., Muller T.E., Monaco A.P., and Chick W.L. Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 252 5006 (1991) 718
235. Lin D.-T., Cheng L.-P., Kang Y.-J., Chen L.-W., and Young T.-H. Effects of precipitation conditions on the membrane morphology and permeation characteristics. J. Membr. Sci. 140 2 (1998) 185
236. Dai W.S., and Barbari T.A. Hydrogel membranes with mesh size asymmetry based on the gradient crosslinking of poly(vinyl alcohol). J. Membr. Sci. 156 1 (1999) 67
237. Risbud M.V., and Bhonde R.R. Suitability of cellulose molecular dialysis membrane for bioartificial pancreas: in vitro biocompatibility studies. J. Biomed. Mater. Res. 54 3 (2001) 436
238. Sakai S., Ono T., Ijima H., and Kawakami K. Synthesis and transport characterization of alginate/aminopropyl-silicate/alginate microcapsule: application to bioartificial pancreas. Biomaterials 22 21 (2001) 2827
239. Sakai S., Ono T., Ijima H., and Kawakami K. In vitro and in vivo evaluation of alginate/sol-gel synthesized aminopropyl-silicate/alginate membrane for bioartificial pancreas. Biomaterials 23 21 (2002) 4177
240. Ikeda H., Kobayashi N., Tanaka Y., Nakaji S., Yong C., Okitsu T., Oshita M., Matsumoto S., Noguchi H., Narushima M., Tanaka K., Miki A., Rivas-Carrillo J.D., Soto-Gutierrez A., Navarro-Álvarez N., Tanaka K., Jun H.-S., Tanaka N., and Yoon J.-W. A newly developed bioartificial pancreas successfully controls blood glucose in totally pancreatectomized diabetic pigs. Tissue Eng. 12 7 (2006) 1799-1809
241. Dulong J.-L., and Legallais C. A theoretical study of oxygen transfer including cell necrosis for the design of a bioartificial pancreas. Biotechol. Bioeng. 96 5 (2007) 990
242. Dulong J.-L., and Legallais C. What are the relevant parameters for the geometrical optimization of an implantable bioartificial pancreas?. J. Biomech. Eng. 127 7 (2005) 1054-1061
243. Leoni L., and Desai T.A. Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations. IEEE Trans. Biomed. Eng. 48 11 (2001) 1335
244. Leoni L., Boiarski A., and Desai T.A. Characterization of nanoporous membranes for immunoisolation: diffusion properties and tissue effects. Biomed. Microdevices 4 2 (2002) 131
245. Desai T.A., West T., Cohen M., Boiarski T., and Rampersaud A. Nanoporous microsystems for islet cell replacement. Adv. Drug Deliv. Rev. 56 11 (2004) 1661
246. Langer R., and Vacanti J.P. Tissue engineering. Science 260 (1993) 920-926
247. Fuchs J.R., Nasseri B.A., and Vacanti J.P. Tissue engineering: a 21st century solution to surgical reconstruction. Annu. Thorac. Surg. 72 (2001) 577-591
248. Hutmacher D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 21 24 (2000) 2529-2543
249. Karageorgiou V., and Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26 (2005) 5474-5491
250. Karande T.S., Ong J.L., and Agrawal C.M. Diffusion in musculoskeletal tissue engineering scaffolds: design issues related to porosity, permeability, architecture, and nutrient mixing. Ann. Biomed. Eng. 32 12 (2004) 1728-1743
251. Agrawal C.M., and Ray R.B. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J. Biomed. Mater. Res. 55 2 (2001) 141-150
252. Falconnet D., Csucs G., Michelle Grandin H., and Textor M. Surface engineering approaches to micropattern surfaces for cell-based assays. Biomaterials 27 16 (2006) 3044-3063
253. Flemming R.G., Murphy C.J., Abrams G.A., Goodman S.L., and Nealey P.F. Effects of synthetic micro- and nano-structured surfaces on cell behavior. Biomaterials 20 6 (1999) 573-588
254. Dunn G.A., and Heath J.P. A new hypothesis of contact guidance in tissue cells. Exp. Cell Res. 101 1 (1976) 1-14
255. Papenburg B.J., Vogelaar L., Bolhuis-Versteeg L.A.M., Lammertink R.G.H., Stamatialis D., and Wessling M. One-step fabrication of porous micropatterned scaffolds to control cell behavior. Biomaterials 28 11 (2007) 1998
256. Rezwan K., Chen Q.Z., Blaker J.J., and Boccaccini A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27 18 (2006) 3413-3431
257. Gunatillake P.A., and Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur. Cells Mater. 5 (2003) 1-16
258. Ramakrishna S., Mayer J., Wintermantel E., and Leong K.W. Biomedical applications of polymer-composite materials: a review. Compos. Sci. Technol. 61 9 (2001) 1189-1224
259. Kim S.Y., Kanamori T., Noumi Y., Wang O.-C., and Shinbo T. Preparation of porous poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) membranes by a phase inversion process and investigation of their morphological changes as cell culture scaffolds. J. Appl. Polym. Sci. 92 (2004) 2082-2092
260. Liu H.-C., Lee I.C., Wang J.-H., Yang S.-H., and Young T.-H. Preparation of PLLA membranes with different morphologies for culture of MG-63 Cells. Biomaterials 25 18 (2004) 4047-4056
261. Zoppi R.A., Contant S., Duek E.A.R., Marques F.R., Wada M.L.F., and Nunes S.P. Porous poly(l-lactide) films obtained by immersion precipitation process: morphology, phase separation and culture of VERO cells. Polymer 40 12 (1999) 3275-3289
262. Guan J., Fujimoto K.L., Sacks M.S., and Wagner W.R. Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications. Biomaterials 26 18 (2005) 3961-3971
263. Li S., Carrubba V.L., Piccarolo S., Sannino D., and Brucato V. Preparation and properties of poly(lactic acid) scaffolds by thermally induced phase separation from a ternary polymer-solvent system. Polym. Int. 53 12 (2004) 2079-2085
264. Hua F.J., Kim G.E., Lee J.D., Son Y.K., and Lee D.S. Macroporous poly(l-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid-liquid phase separation of a PLLA-dioxane-water system. J. Biomed. Mater. Res. 63 2 (2002) 161-167
265. Nam Y.S., and Park T.G. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J. Biomed. Mater. Res. 47 1 (1999) 8-17
266. Vaquette C., Fawzi-Grancher S., Lavalle P., Frochot C., Viriot M.L., Muller S., and Wang X. In vitro biocompatibility of different polyester membranes. Bio-Med. Mater. Eng. 16 4 (2006) S131-S136
267. Htay A.S., Teoh S.H., and Hutmacher D.W. Development of perforated microthin poly(epsilon-caprolactone) films as matrices for membrane tissue engineering. J. Biomater. Sci. Polym. Ed. 15 5 (2004) 683-700
268. Tanaka M., Takebayashi M., Miyama M., Nishida J., and Shimomura M. Design of novel biointerfaces (II). Fabrication of self-organized porous polymer film with highly uniform pores. Bio-Med. Mater. Eng. 14 4 (2004) 439-446
269. Park Y.J., Nam K.H., Ha S.J., Pai C.M., Chung C.P., and Lee S.J. Porous poly(l-lactide) membranes for guided tissue regeneration and controlled drug delivery: membrane fabrication and characterization. J. Controll. Release 43 2-3 (1997) 151-160
270. Causa F., Netti P.A., Ambrosio L., Ciapetti G., Baldini N., Pagani S., Martini D., and Giunti A. Poly-ε-caprolactone/hydroxyapatite composites for bone regeneration: in vitro characterization and human osteoblast response. J. Biomed. Mater. Res. Part A 76A 1 (2006) 151-162
271. Vogelaar L., Barsema J.N., Rijn C.J.M.v., Nijdam W., and Wessling M. Phase separation micromolding-PSμM. Adv. Mater. 15 16 (2003) 1385-1389
272. De Jong J., Ankone B., Lammertink R.G.H., and Wessling M. New replication technique for the fabrication of thin polymeric microfluidic devices with tunable porosity. Lab on a Chip; Miniatur. Chem. Biol. Bioeng. 5 11 (2005) 1240
273. C.J.M. Van Rijn, L. Vogelaar, W. Nijdam, J.N. Barsema, M. Wessling, WO 02/43937 A2, Method of making a product with a micro or nano sized structure and product, 2002.
274. Ellis M.J., and Chaudhuri J.B. Poly(lactic-co-glycolic acid) hollow fibre membranes for use as a tissue engineering scaffold. Biotechnol. Bioeng. 96 1 (2007) 177-187
275. Ho M.-H., Kuo P.-Y., Hsieh H.-J., Hsien T.-Y., Hou L.-T., Lai J.-Y., and Wang D.-M. Preparation of porous scaffolds by using freeze-extraction and freeze-gelation methods. Biomaterials 25 1 (2004) 129-138
276. Whang K., Thomas C.H., Healy K.E., and Nuber G. A novel method to fabricate bioabsorbable scaffolds. Polymer 36 4 (1995) 837-842
277. Wang X., Li W., and Kumar V. A method for solvent-free fabrication of porous polymer using solid-state foaming and ultrasound for tissue engineering applications. Biomaterials 27 9 (2006) 1924-1929
278. Singh L., Kumar V., and Ratner B.D. Generation of porous microcellular 85/15 poly(-lactide-co-glycolide) foams for biomedical applications. Biomaterials 25 13 (2004) 2611-2617
279. Harris L.D., Kim B.-S., and Mooney D.J. Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mater. Res. 42 3 (1998) 396-402
280. Lips P.A.M., Velthoen I.W., Dijkstra P.J., Wessling M., and Feijen J. Gas foaming of segmented poly(ester amide) films. Polymer 46 22 (2005) 9396-9403
281. Kim S.-S., Sun Park M., Jeon O., Yong Choi C., and Kim B.-S. Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 27 8 (2006) 1399-1409
282. Krause B., Koops G.H., Van Der Vegt N.F.A., Wessling M., Wu?bbenhorst M., and Van Turnhout J. Ultralow-k dielectrics made by supercritical foaming of thin polymer films. Adv. Mater. 14 15 (2002) 1041-1046
283. Krause B., Mettinkhof R., Van Der Vegt N.F.A., and Wessling M. Microcellular foaming of amorphous high-Tg polymers using carbon dioxide. Macromolecules 34 4 (2001) 874-884
284. Krause B., Van Der Vegt N.F.A., and Wessling M. Open nanoporous morphologies from polymeric blends by carbon dioxide foaming. Macromolecules 35 5 (2002) 1738-1745
285. RoyChowdhury P., and Kumar V. Fabrication and evaluation of porous 2,3-dialdehydecellulose membrane as a potential biodegradable tissue-engineering scaffold. J. Biomed. Mater. Res. Part A 76A 2 (2006) 300-309
286. Ma P.X., and Choi J.-W. Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. Tissue Eng. 7 1 (2001) 23-33
287. Katoh K., Tanabe T., and Yamauchi K. Novel approach to fabricate keratin sponge scaffolds with controlled pore size and porosity. Biomaterials 25 18 (2004) 4255-4262
288. Bhattarai S.R., Bhattarai N., Viswanathamurthi P., Yi H.K., Hwang P.H., and Kim H.Y. Hydrophilic nanofibrous structure of polylactide; fabrication and cell affinity. J. Biomed. Mater. Res. Part A 78A 2 (2006) 247-257
289. Riboldi S.A., Sampaolesi M., Neuenschwander P., Cossu G., and Mantero S. Electrospun degradable polyesterurethane membranes: potential scaffolds for skeletal muscle tissue engineering. Biomaterials 26 22 (2005) 4606-4615
290. Boudriot U., Dersch R., Greiner A., and Wendorff J.H. Electrospinning approaches toward scaffold engineering-a brief overview. Artif. Organs 30 10 (2006) 785
291. Moroni L., Licht R., de Boer J., de Wijn J.R., and van Blitterswijk C.A. Fiber diameter and texture of electrospun PEOT/PBT scaffolds influence human mesenchymal stem cell proliferation and morphology, and the release of incorporated compounds. Biomaterials 27 28 (2006) 4911
292. Buttafoco L., Kolkman N.G., Engbers-Buijtenhuijs P., Poot A.A., Dijkstra P.J., Vermes I., and Feijen J. Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 27 5 (2006) 724-734
293. Deisinger U., Stenzel F., and Ziegler G. Development of hydroxyapatite ceramics with tailored pore structure. Bioceramics 16 254-2 (2004) 977-980
294. Jones I., Currie L., and Martin R. A guide to biological skin substitutes. Br. J. Plastic Surg. 55 3 (2002) 185
295. Zimmermann W.H., and Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail. Rev. 8 3 (2003) 259-269
296. Shachar M., and Cohen S. Cardiac Tissue Engineering, Ex Vivo: design principles in biomaterials and bioreactors. Heart Fail. Rev. 8 3 (2004) 271-276
297. De Bartolo L., Salerno S., Giorno L., Morelli S., Barbieri G., Curcio E., Rende M., and Drioli E. Membrane bioreactor using pig hepatocytes for in vitro evaluation of anti-inflammatory drugs. Catal. Today 118 1-2 (2006) 172
298. Drioli E., and De Bartolo L. Membrane bioreactor for cell tissues and organoids. Artif. Organs 30 10 (2006) 793
299. Feng Zhao T.M. Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development. Biotechnol. Bioeng. 91 4 (2005) 482-493
300. Bancroft G.N., Sikavitsas V.I., and Mikos A.G. Technical note: design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng. 9 3 (2003) 549-554
301. Ye H., Das D.B., Triffitt J.T., and Cui Z. Modelling nutrient transport in hollow fibre membrane bioreactors for growing three-dimensional bone tissue. J. Membr. Sci. 272 1-2 (2006) 169-178
302. Williams C., and Wick T.M. Endothelial cell-smooth muscle cell co-culture in a perfusion bioreactor system. Ann. Biomed. Eng. 33 7 (2005) 920
303. Sikavitsas V.I., Bancroft G.N., Holtorf H.L., Jansen J.A., and Mikos A.G. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. PNAS 100 25 (2003) 14683-14688
304. Hoerstrup S.P., Zund G., Sodian R., Schnell A.M., Grunenfelder J., and Turina M.I. Tissue engineering of small caliber vascular grafts. Eur. J. Cardio-Thorac. Surg. 20 1 (2001) 164
305. Kannan R.Y., Salacinski H.J., Sales K., Butler P., and Seifalian A.M. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials 26 14 (2005) 1857
306. Rue Iii L.W., Cioffi W.G., McManus W.F., and Pruitt Jr. B.A. Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. J. Trauma 34 5 (1993) 662
307. Boyce S.T. Cultured skin substitutes: a review. Tissue Eng. 2 4 (1996) 255
308. Sun T., Norton D., Haycock J.W., Ryan A.J., and MacNeil S. Development of a closed bioreactor system for culture of tissue-engineered skin at an air-liquid interface. Tissue Eng. 11 11-12 (2005) 1824
309. Rabkin E., and Schoen F.J. Cardiovascular tissue engineering. Cardiovasc. Pathol. 11 6 (2002) 305-317
310. Narine K.K., Kramm K., Dumont K., Jalali H., Sparks L., Segers P., Verdonck P., and Van Nooten G.J. Hydrodynamic evaluation of kangaroo aortic valve matrices for tissue valve engineering. Artif. Organs 30 6 (2006) 432-439
311. George C., Engelmayr Jr. S.S., and Michael. A structural model for the flexural mechanics of nonwoven tissue engineering scaffolds. J. Biomech. Eng. 128 4 (2006) 610-622
312. Mol A., Driessen N.J.B., Rutten M.C.M., Hoerstrup S.P., Bouten C.V.C., and Baaijens F.P.T. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning. Ann. Biomed. Eng. 33 12 (2005) 1778-1788
313. Skett P. Problems in using isolated and cultured hepatocytes for xenobiotic metabolism/metabolism-based toxicity testing-solutions?. Toxicol. In Vitro 8 (1994) 491-504
314. Deglmann C.J., Metzger R., Stickel M., Hoerrlein S., Schildberg F.W., and Koebe H.G. A new bioassay including a small scale hepatocyte bioreactor for hepato-mediated toxicity testing in a target cell line. Int. J. Artif. Organs 25 10 (2002) 975-984
315. Sivaraman A., Leach J.K., Townsend S., Iida T., Hogan B.J., Stolz D.B., Fry R., Samson L.D., Tannenbaum S.R., and Griffith L.G. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr. Drug Metab. 6 6 (2005) 569-591
316. De Bartolo L., Salerno S., Morelli S., Giorno L., Rende M., Memoli B., Procino A., Andreucci V.E., Bader A., and Drioli E. Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor. Biomaterials 27 27 (2006) 4794-4803
317. Schmitmeier S., Langsch A., Jasmund I., and Bader A. Development and characterization of a small-scale bioreactor based on a bioartificial hepatic culture model for predictive pharmacological in vitro screenings. Biotechnol. Bioeng. (2006)
318. Meng Q., Zhang G., Shen C., and Qiu H. Sensitivities of gel entrapped hepatocytes in hollow fibers to hepatotoxic drug. Toxicol. Lett. 166 1 (2006) 19-26
319. Vernon R.B., Gooden M.D., Lara S.L., and Wight T.N. Microgrooved fibrillar collagen membranes as scaffolds for cell support and alignment. Biomaterials 26 16 (2005) 3131-3140
320. Singhvi R., Stephanopoulos G., and Wang D.I.C. Effects of substratum morphology on cell physiology. Biotechnol. Bioeng. 43 8 (1994) 764-771
321. Tsang V.L., and Bhatia S.N. Three-dimensional tissue fabrication. Adv. Drug Deliv. Rev. 56 11 (2004) 1635-1647
322. Vozzi G., Flaim C., Ahluwalia A., and Bhatia S. Fabrication of PLGA scaffolds using soft lithography and microsyringe deposition. Biomaterials 24 (2003) 2533-2540
323. Borenstein J.T., Terai H., King K.R., Weinberg E.J., Kaazempur-Mofrad M.R., and Vacanti J.P. Microfabrication technology for vascularized tissue engineering. Biomed. Microdevices 4 3 (2002) 167-175
324. Rickert D., Moses M.A., Lendlein A., Kelch S., and Franke R.P. The importance of angiogenesis in the interaction between polymeric biomaterials and surrounding tissue. Clin. Hemorheol. Microcirc. 28 3 (2003) 175
325. Fong P., Shin'oka T., Lopez-Soler R.I., and Breuer C. The use of polymer based scaffolds in tissue-engineered heart valves. Prog. Pediatr. Cardiol. 21 2 (2006) 193-199
326. Matsumura G., Hibino N., Ikada Y., Kurosawa H., and Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24 13 (2003) 2303-2308
327. Anderson D.G., Putman D., Lavik E.B., Mahmood T.A., and Langer R. Biomaterial microarrays: rapid, microscale screening of polymer-cell interaction. Biomaterials 26 (2005) 4892-4897
328. Andersson H., and van den Berg A. Microfluidic devices for cellomics: a review. Sens. Actuators B Chem. 92 3 (2003) 315
329. Andersson H., and Van Den Berg A. Microtechnologies and nanotechnologies for single-cell analysis. Curr. Opin. Biotechnol. 15 1 (2004) 44
330. Andersson H., and van de Berg A. Microfabrication and microfluidics for tissue engineering: state of the art and future opportunities. Lab on a Chip; Miniatur. Chem. Biol. Bioeng. 4 (2004) 98-103
331. El-Ali J., Sorger P.K., and Jensen K.V. Cells on chips. Nature 442 (2006) 403-411
332. De Jong J., Lammertink R.G.H., and Wessling M. Membranes and microfluidics: a review. Lab on a Chip; Miniatur. Chem. Biol. Bioeng. 6 9 (2006) 1125